Foster City, CA, United States of America

Ramakrishna Gadiraju

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Nektar Therapeutics. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ramakrishna Gadiraju. Retrieved from https://idiyas.com/inventor/ramakrishna-gadiraju

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ramakrishna Gadiraju: Innovator in Opioid Agonist Solid Forms

Introduction

Ramakrishna Gadiraju is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid forms of certain opioid agonists. His work is essential in enhancing the efficacy and usability of these compounds.

Latest Patents

Ramakrishna Gadiraju holds 1 patent related to his innovative work. The patent focuses on solid forms of certain opioid agonists, providing methods for preparing these solid forms, as well as methods of using them and pharmaceutical compositions that include these solid forms.

Career Highlights

He is currently employed at Nektar Therapeutics, a company known for its advancements in drug delivery and therapeutic solutions. His role at Nektar Therapeutics allows him to apply his expertise in pharmaceutical sciences to develop new and effective treatments.

Collaborations

Ramakrishna has collaborated with notable colleagues, including Patricia Andres and Yogesh Datar. These collaborations have likely contributed to the innovative environment at Nektar Therapeutics, fostering advancements in pharmaceutical research.

Conclusion

Ramakrishna Gadiraju's work in the field of opioid agonists represents a significant advancement in pharmaceutical innovation. His contributions are vital for the development of effective treatments that can improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…